Deutsche Bank AG Purchases 51,232 Shares of Avantor, Inc. $AVTR

Deutsche Bank AG grew its position in shares of Avantor, Inc. (NYSE:AVTR - Free Report) by 3.3% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 1,596,824 shares of the company's stock after purchasing an additional 51,232 shares during the quarter. Deutsche Bank AG owned approximately 0.23% of Avantor worth $25,885,000 as of its most recent SEC filing.

A number of other hedge funds have also recently made changes to their positions in AVTR. Tidal Investments LLC raised its position in shares of Avantor by 59.6% during the fourth quarter. Tidal Investments LLC now owns 18,869 shares of the company's stock worth $398,000 after purchasing an additional 7,048 shares during the period. US Bancorp DE increased its position in shares of Avantor by 85.5% during the 1st quarter. US Bancorp DE now owns 11,135 shares of the company's stock valued at $180,000 after purchasing an additional 5,133 shares during the last quarter. Cetera Investment Advisers lifted its stake in Avantor by 33.6% in the first quarter. Cetera Investment Advisers now owns 28,746 shares of the company's stock valued at $466,000 after purchasing an additional 7,227 shares during the last quarter. GAMMA Investing LLC raised its stake in Avantor by 121.6% in the 1st quarter. GAMMA Investing LLC now owns 3,747 shares of the company's stock valued at $61,000 after acquiring an additional 2,056 shares during the period. Finally, Fifth Third Bancorp raised its stake in Avantor by 52.0% in the 1st quarter. Fifth Third Bancorp now owns 3,972 shares of the company's stock valued at $64,000 after acquiring an additional 1,359 shares during the period. 95.08% of the stock is owned by institutional investors and hedge funds.

Avantor Stock Performance

Shares of Avantor stock traded up $0.03 during trading on Monday, hitting $12.96. 2,543,471 shares of the company's stock traded hands, compared to its average volume of 10,654,052. The company has a debt-to-equity ratio of 0.48, a current ratio of 0.98 and a quick ratio of 0.67. Avantor, Inc. has a 1 year low of $10.82 and a 1 year high of $27.83. The stock has a market capitalization of $8.83 billion, a P/E ratio of 13.07, a PEG ratio of 1.46 and a beta of 0.96. The business has a 50-day simple moving average of $13.19 and a 200-day simple moving average of $14.70.

Avantor (NYSE:AVTR - Get Free Report) last announced its earnings results on Friday, August 1st. The company reported $0.24 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.25 by ($0.01). The firm had revenue of $1.68 billion during the quarter, compared to analysts' expectations of $1.67 billion. Avantor had a return on equity of 11.39% and a net margin of 10.31%. The company's revenue for the quarter was down 1.1% on a year-over-year basis. During the same period in the previous year, the business posted $0.25 earnings per share. As a group, analysts forecast that Avantor, Inc. will post 1.06 EPS for the current year.

Insider Activity

In other Avantor news, Director Gregory L. Summe bought 30,000 shares of the firm's stock in a transaction that occurred on Friday, May 23rd. The shares were bought at an average price of $12.50 per share, with a total value of $375,000.00. Following the purchase, the director owned 100,000 shares of the company's stock, valued at $1,250,000. This trade represents a 42.86% increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CAO Steven W. Eck sold 3,476 shares of Avantor stock in a transaction that occurred on Tuesday, August 5th. The shares were sold at an average price of $11.39, for a total value of $39,591.64. Following the sale, the chief accounting officer directly owned 55,068 shares in the company, valued at $627,224.52. This trade represents a 5.94% decrease in their position. The disclosure for this sale can be found here. 1.20% of the stock is owned by company insiders.

Analyst Ratings Changes

Several research analysts have commented on AVTR shares. The Goldman Sachs Group downgraded Avantor from a "buy" rating to a "neutral" rating and cut their target price for the stock from $23.00 to $14.00 in a research note on Tuesday, April 29th. JPMorgan Chase & Co. decreased their price target on Avantor from $17.00 to $14.00 and set an "overweight" rating on the stock in a research note on Monday, August 4th. Robert W. Baird reduced their price target on Avantor from $18.00 to $15.00 and set an "outperform" rating on the stock in a report on Monday, August 4th. TD Cowen cut Avantor from a "buy" rating to a "hold" rating and set a $15.50 target price on the stock. in a research note on Monday, April 28th. Finally, Morgan Stanley reduced their price target on Avantor from $15.00 to $12.00 and set an "equal weight" rating on the stock in a research note on Monday, August 4th. Eight analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company's stock. According to data from MarketBeat, the company currently has a consensus rating of "Hold" and an average price target of $15.50.

Avantor Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.